5.15 -0.05 (-0.96%)
ONCY
| Trade ONCY now with |
|
Stock Details
Last Trade:5.15 Change:-0.05 (-0.96%) Prev Close:5.20 Open: 5.20 Days Range:5.05 – 5.20 52 Week Range: 3.15 - 6.69 Volume:63458 P/E: N/AEPS:0.00
View AllRecent Alerts 02/09/12
Recent Alert on 01/30/12 at 2:23pm
Unusual 11 Midday Movers 01/30: (GTXI) (ONCY) (PBY) Higher; (CTIC) (EMKR) (PMC) Lower
Unusual 11 Midday Movers 01/30: (GTXI) (ONCY) (PBY) Higher; (CTIC) (EMKR) (PMC) Lower
GTX Inc. (NASDAQ: GTXI) 52.3% HIGHER; Citi more than doubled its price target on GTX from $8 to $19 citing a high likelihood of Phase 3 success of ostarine. The firm said ostarine could attract interest from biopharma companies. Oncolytics... Read More
Recent Alert on 01/23/12 at 4:20pm
Oncolytics Biotech (ONCY) Announcs Offering of 3.57M Shares for Cdn$4.20/Share
Oncolytics Biotech (ONCY) Announcs Offering of 3.57M Shares for Cdn$4.20/Share
Recent Alert on 12/02/11 at 7:05am
Oncolytics (ONCY) Reports REOLYSIN Phase 2 in Combo w/ Gemzar Met Primary Endpoint
Oncolytics (ONCY) Reports REOLYSIN Phase 2 in Combo w/ Gemzar Met Primary Endpoint
Recent Alert on 12/02/11 at 7:05am
Oncolytics (ONCY) Reports REOLYSIN Phase 2 in Combo w/ Gemzar Met Primary Endpoint
Oncolytics (ONCY) Reports REOLYSIN Phase 2 in Combo w/ Gemzar Met Primary Endpoint
Recent Alert on 11/14/11 at 7:03am
Oncolytics (ONTY) Reports Positve Results from REOLYSIN Phase 2 in Advanced Head, Neck Cancer Patients
Oncolytics (ONTY) Reports Positve Results from REOLYSIN Phase 2 in Advanced Head, Neck Cancer Patients
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 04/08/11 at 7:11am
Cramer's Mad Money - My Most Unpopular Call in the Last Six Years (4/7/11)
Cramer's Mad Money - My Most Unpopular Call in the Last Six Years (4/7/11)
Blog Posts on 03/28/11 at 10:48am
4 Biotech Companies With a Two-Year Cash Cushion, Being Snapped Up by the Smart Money
4 Biotech Companies With a Two-Year Cash Cushion, Being Snapped Up by the Smart Money